UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2012  

Commission File Number 001-34974

__________________________

 

AEROFLEX HOLDING CORP.

 

(Exact name of Registrant as specified in its Charter)

 

DELAWARE   01-0899019
(State or other jurisdiction   (I.R.S. Employer
of incorporation or organization)   Identification No.)

 

35 South Service Road    
P.O. Box 6022    
Plainview, N.Y.   11803-0622
(Address of principal executive offices)   (Zip Code)

 

  (516) 694-6700  
  (Registrant’s telephone number, including area code)  
     

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer ¨ Accelerated filer x
Non-accelerated filer ¨ Smaller reporting company ¨
(Do not check if a smaller reporting company)  

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ¨ No x

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.


November 7, 2012   84,851,868
(Date)   (Number of Shares)

 

 
 

 

 

AEROFLEX HOLDING CORP.

AND SUBSIDIARIES

INDEX

 

  PAGE
  PART I: FINANCIAL INFORMATION  
     
Item 1 UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS  
September 30, 2012 and June 30, 2012 2
     
  UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS  
  Three Months Ended September 30, 2012 and 2011 3
     
  UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)  
  Three Months Ended September 30, 2012 and 2011 4
     
  UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS  
  Three Months Ended September 30, 2012 and 2011 5
     
  NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 6 – 13
     
Item 2 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS  
Three Months Ended September 30, 2012 and 2011 14 – 22
     
Item 3 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 23
     
Item 4 CONTROLS AND PROCEDURES 23
     
  PART II: OTHER INFORMATION  
     
Item 1 LEGAL PROCEEDINGS 24
     
Item 1A RISK FACTORS 24
     
Item 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 24
     
Item 3 DEFAULTS UPON SENIOR SECURITIES 24
     
Item 4 MINE SAFETY DISCLOSURES 24
     
Item 5 OTHER INFORMATION 24
     
Item 6 EXHIBITS 25
     
SIGNATURE 26
   
EXHIBIT INDEX 27
   
CERTIFICATIONS  

 

1
 

 

Aeroflex Holding Corp. and Subsidiaries

Unaudited Condensed Consolidated Balance Sheets

(In thousands, except share and per share data)

 

   September 30,   June 30, 
   2012   2012 
Assets          
Current assets:          
Cash and cash equivalents  $45,235   $41,324 
Accounts receivable, less allowance for doubtful accounts of $1,527 and $981   113,547    146,597 
Inventories   158,318    158,090 
Deferred income taxes   29,825    33,315 
Income taxes receivable   5,076    4,935 
Prepaid expenses and other current assets   12,984    11,942 
Total current assets   364,985    396,203 
           
          
Property, plant and equipment, net of accumulated depreciation of $107,813 and $102,310   102,341    101,632 
Deferred financing costs, net   14,569    15,720 
Other assets   32,334    34,955 
Intangible assets with definite lives, net   108,057    119,476 
Intangible assets with indefinite lives   114,206    113,461 
Goodwill   410,124    408,361 
           
Total assets  $1,146,616   $1,189,808 
           
Liabilities and Stockholders' Equity          
Current liabilities:          
Accounts payable  $25,144   $26,822 
Advance payments by customers and deferred revenue   21,660    23,433 
Income taxes payable   417    593 
Accrued payroll expenses   18,970    18,635 
Accrued expenses and other current liabilities   36,654    37,559 
Total current liabilities   102,845    107,042 
           
Long-term debt   616,375    641,375 
Deferred income taxes   88,186    94,022 
Other long-term liabilities   20,386    20,592 
Total liabilities   827,792    863,031 
           
Stockholders' equity:          
Preferred stock, par value $.01 per share; 50,000,000 shares authorized,          
no shares issued and outstanding   -    - 
Common stock, par value $.01 per share; 300,000,000 shares authorized;          
84,851,868 and 84,845,687 shares issued and outstanding   848    848 
Additional paid-in capital   648,801    648,092 
Accumulated other comprehensive income (loss)   (33,999)   (39,476)
Accumulated deficit   (296,826)   (282,687)
Total stockholders' equity   318,824    326,777 
           
Total liabilities and stockholders' equity  $1,146,616   $1,189,808 

 

See notes to unaudited condensed consolidated financial statements.

 

2
 

 

Aeroflex Holding Corp. and Subsidiaries

Unaudited Condensed Consolidated Statements of Operations

(In thousands, except per share data)

 

   Three Months Ended September 30, 
   2012   2011 
         
Net sales  $141,153   $154,884 
Cost of sales   72,254    76,365 
Gross profit   68,899    78,519 
           
Operating expenses:          
Selling, general and administrative costs   35,703    37,131 
Research and development costs   20,878    24,275 
Amortization of acquired intangibles   14,580    15,736 
Restructuring charges   3,267    436 
Change in fair value of acquisition contingent  consideration liability   -    403 
Total operating expenses   74,428    77,981 
Operating income (loss)   (5,529)   538 
           
Other income (expense):          
Interest expense   (10,078)   (8,574)
Write-off of deferred financing costs   (597)   - 
Other income (expense), net   (289)   (295)
Total other income (expense), net   (10,964)   (8,869)
           
Income (loss) before income taxes   (16,493)   (8,331)
Provision (benefit) for income taxes   (2,354)   (3,289)
Net income (loss)  $(14,139)  $(5,042)
           
Net income (loss) per common share:          
Basic and diluted  $(0.17)  $(0.06)
           
Weighted average number of common shares outstanding:          
Basic and diluted   84,836    84,789 

 

See notes to unaudited condensed consolidated financial statements.

 

 

3
 

 

 

Aeroflex Holding Corp. and Subsidiaries
Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss)
(In thousands)

  

   Three Months Ended September 30, 
   2012   2011 
         
Net income (loss)  $(14,139)  $(5,042)
           
Other comprehensive income (loss):          
Foreign currency translation adjustment, net of tax provision (benefit) of $192 and $(316)   5,477    (7,378)
           
Total comprehensive income (loss)  $(8,662)  $(12,420)

 

See notes to unaudited condensed consolidated financial statements.

 

 

4
 

 

 

Aeroflex Holding Corp. and Subsidiaries

Unaudited Condensed Consolidated Statements of Cash Flows

(In thousands)

 

   Three Months Ended September 30, 
   2012   2011 
Cash flows from operating activities:          
Net income (loss)  $(14,139)  $(5,042)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:          
Depreciation and amortization   20,123    20,974 
Change in fair value of acquisition contingent consideration liability   -    403 
Write-off of deferred financing costs   597    - 
Deferred income taxes   (2,629)   394 
Share-based compensation   636    600 
Amortization of deferred financing costs   554    502 
Other, net   511    426 
Change in operating assets and liabilities:          
Decrease (increase) in accounts receivable   33,023    23,582 
Decrease (increase) in inventories   94    (10,774)
Decrease (increase) in prepaid expenses and other assets   (1,438)   (2,249)
Increase (decrease) in accounts payable, accrued expenses and other liabilities   (5,338)   (29,985)
           
 Net cash provided by (used in) operating activities   31,994    (1,169)
           
 Cash flows from investing activities:          
Capital expenditures   (4,087)   (4,713)
Other, net   248    4 
           
 Net cash provided by (used in) investing activities   (3,839)   (4,709)
           
 Cash flows from financing activities:          
Debt repayments   (25,000)   (1,812)
Deferred financing costs   -    (82)
Other, net   (21)   - 
           
 Net cash provided by (used in) financing activities   (25,021)   (1,894)
           
 Effect of exchange rate changes on cash and cash equivalents   777    (1,020)
           
 Net increase (decrease) in cash and cash equivalents   3,911    (8,792)
 Cash and cash equivalents at beginning of period   41,324    66,278 
           
 Cash and cash equivalents at end of period  $45,235   $57,486 

 

See notes to unaudited condensed consolidated financial statements.

 

5
 

 

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

1. Basis of Presentation

 

The accompanying unaudited condensed consolidated financial information of Aeroflex Holding Corp. and subsidiaries (“we”, “our”, “us”, or the “Company”) has been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and the rules and regulations of the United States Securities and Exchange Commission (“SEC”), and reflects all adjustments, consisting only of normal recurring adjustments, which in management’s opinion are necessary to state fairly the Company’s financial position as of September 30, 2012, its results of operations for the three month periods ended September 30, 2012 and 2011 and its cash flows for the three month periods ended September 30, 2012 and 2011. The June 30, 2012 balance sheet information has been derived from audited financial statements, but does not include all information or disclosures required by U.S. GAAP.

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of sales and expenses during the reporting period. Actual results may differ from those estimates, and such differences may be material to the financial statements.

 

These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in our annual report on Form 10-K for the fiscal year ended June 30, 2012 (“the fiscal 2012 Form 10-K”).

 

Unless the context requires otherwise, (i) “Sponsors” refers collectively to affiliates of or funds managed by The Veritas Capital Fund III, L.P., Golden Gate Private Equity, Inc., and GS Direct, L.L.C., which indirectly control the Company and (ii) “fiscal” refers to the twelve months ended June 30 of the applicable year. For example, “fiscal 2012” refers to the twelve months ended June 30, 2012.

 

Results of operations for interim periods are not necessarily indicative of results to be expected for the full fiscal year or any future periods.

 

2. Recent Accounting Pronouncements

 

In June 2011, the Financial Accounting Standards Board (“FASB”) issued authoritative guidance on the presentation of comprehensive income. The new guidance eliminates the option to report other comprehensive income and its components in the statement of stockholders’ equity. Instead, an entity is required to present either a continuous statement of net income and other comprehensive income or two separate but consecutive statements. The new guidance also requires entities to present reclassification adjustments out of accumulated other comprehensive income by component in both the statement in which net income is presented and the statement in which other comprehensive income is presented. This new guidance became effective for us beginning with the first quarter of fiscal 2013 and was applied retrospectively. We have presented other comprehensive income in a separate statement immediately following our Statement of Operations. In December 2011, the FASB issued guidance which indefinitely defers the guidance related to the presentation of reclassification adjustments.

 

In September 2011, the FASB issued authoritative guidance on testing goodwill for impairment. The new guidance provides an entity the option to first perform a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines that this is the case, it is required to perform the currently prescribed two-step goodwill impairment test to identify potential goodwill impairment and measure the amount of goodwill impairment loss to be recognized for that reporting unit (if any). If an entity determines that the fair value of a reporting unit exceeds its carrying amount, the two-step goodwill impairment test is not required. This new guidance became effective for us beginning with the first quarter of fiscal 2013. The adoption of this new guidance did not have an impact on our consolidated financial statements.

 

6
 

 

In July 2012, the FASB issued authoritative guidance allowing entities to use a qualitative approach to test indefinite-lived intangible assets for impairment. The new guidance permits an entity to first perform a qualitative assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying value. If it is concluded that this is the case, it is necessary to perform the currently prescribed quantitative impairment test by comparing the fair value of the indefinite-lived intangible asset with its carrying value. Otherwise, the quantitative impairment test is not required. We adopted this guidance in the first quarter of fiscal 2013. The adoption of the new guidance did not have an impact on our consolidated financial statements.

 

3. Goodwill and Other Intangible Assets

 

We assess goodwill and other intangible assets with indefinite lives at least annually for impairment in the fourth quarter of our fiscal year, or more frequently if certain events or circumstances indicate an impairment may have occurred. We test goodwill for impairment at the reporting unit level, which is one level below our operating segments.

 

The carrying amount of goodwill, by segment, was as follows:

 

   Microelectronic   Test     
   Solutions   Solutions   Total 
   (In thousands) 
             
Balance at June 30, 2012  $248,090   $160,271   $408,361 
Translation adjustments   856    907    1,763 
Balance at September 30, 2012  $248,946   $161,178   $410,124 

 

The components of amortizable intangible assets were as follows:

 

   September 30, 2012       June 30, 2012 
   Gross           Gross         
   Carrying   Accumulated   Total Net   Carrying   Accumulated   Total Net 
   Amount   Amortization   Book Value   Amount   Amortization   Book Value 
   (In thousands) 
                         
Developed technology  $203,350   $172,802   $30,548   $199,489   $164,065   $35,424 
Customer related intangibles   227,419    152,961    74,458    226,865    146,259    80,606 
Non-compete arrangements   10,379    8,429    1,950    10,292    8,007    2,285 
Trade names   3,354    2,253    1,101    3,298    2,137    1,161 
 Total  $444,502   $336,445   $108,057   $439,944   $320,468   $119,476 
                               

 

7
 

 

4. Restructuring Charges

 

The following table sets forth the charges and payments related to the restructuring liability, which is reflected in accrued expenses and other current liabilities in the accompanying condensed consolidated balance sheets for the periods indicated:

 

   Balance               Balance 
   June 30,               September 30, 
   2012   Three Months Ended September 30, 2012   2012 
               Effect of     
   Restructuring       Cash   Foreign   Restructuring 
   Liability   Net Additions   Payments   Currency   Liability 
       (In thousands)     
                     
Severance costs  $2,085   $2,500   $(2,759)  $47   $1,873 
                          
Facilities closure costs   502    767    (449)   -    820 
                          
Total  $2,587   $3,267   $(3,208)  $47   $2,693 

 

In the three months ended September 30, 2012, we implemented headcount reductions of 53 employees and closed our ATS Hong Kong office in order to continue to right size the business.

 

5. Inventories

 

Inventories consisted of the following:

 

   September 30,   June 30, 
   2012   2012 
   (In thousands) 
         
Raw materials  $82,431   $82,202 
Work in process   47,945    45,067 
Finished goods   27,942    30,821 
   $158,318   $158,090 

 

6. Derivative Financial Instruments

 

We address certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments. When deemed appropriate to do so, we enter into interest rate swap derivatives to manage the effects of interest rate movements on portions of our debt. We routinely enter into foreign currency forward contracts, not designated as hedging instruments, to protect us from fluctuations in exchange rates.

 

Foreign Currency Contract Derivatives

 

Foreign currency contracts are used to protect us from fluctuations in exchange rates. Our foreign currency contracts are not designated as hedges and therefore the change in fair value is included in other income (expense) as it occurs. As of September 30, 2012, we had $31.4 million of notional value foreign currency forward contracts maturing through October 31, 2012. Notional amounts do not quantify risk or represent assets or liabilities of the Company, but are used in the calculation of cash settlements under the contracts.

 

 

 

8
 

 

 

The fair values of our derivative financial instruments included in the consolidated balance sheets as of September 30, 2012 and June 30, 2012 were as follows:

 

   Asset (Liability) Derivatives
   September 30, 2012  June 30, 2012
   Balance Sheet      Balance Sheet    
   Location  Fair Value (1)   Location  Fair Value (1) 
   (In thousands)
               
Derivatives not designated as hedging instruments:                
Foreign currency forward contracts  Accrued expenses and other current liabilities  $(2)  Prepaid expenses and other current assets  $23 

 

(1)The fair values of derivative assets and liabilities are determined based on observable market data and are considered level 2 in the fair value hierarchy.

 

The amounts of the gains and losses related to our derivative financial instruments not designated as hedging instruments for the three months ended September 30, 2012 and 2011 were as follows:

 

Derivatives Not  Location of Gain or (Loss)    Amount of Gain or (Loss)
Designated as  Recognized in Earnings on    Recognized in Earnings on
Hedging Instruments  Derivative    Derivative
        Three Months Ended September 30,
        2012  2011 
        (In thousands)
Foreign currency  forward contracts  Other income (expense)  $ (25) $156 

 

7. Long Term Debt and Credit Agreements

 

On May 24, 2012, we amended our senior secured credit facility, which allowed us to increase the flexibility under the total leverage ratio covenant. As of result of the amendment, the applicable LIBOR interest margin increased from 300 basis points to 450 basis points.

 

For the three months ended September 30, 2012, we voluntarily prepaid $25.0 million of our term loan with cash on hand from operations. The voluntary prepayment resulted in the write-off of the related deferred financing costs of $597,000.

 

As of September 30, 2012, we were in compliance with all of the financial covenants contained in the senior secured credit facility.

 

Interest paid was $9.2 million and $8.0 million for the three months ended September 30, 2012 and 2011, respectively. Accrued interest of $5.2 million and $5.1 million was included in accrued expenses and other current liabilities at September 30, 2012 and June 30, 2012, respectively.

 

9
 

 

The fair value of our debt instruments was as follows:

 

     As of September 30, 2012
    Carrying Amount  Estimated Fair Value 
     (In thousands)
           
Senior secured term loan facility  $ 616,375  $618,671 

 

As of June 30, 2012, our total debt had a carrying value of $641.4 million and a fair value of $622.1 million.

 

The estimated fair values of each of our debt instruments were based on quoted prices and are considered Level 2 measurements. Fair value estimates related to our debt instruments are made at a specific point in time based on relevant market information. The estimates are subjective in nature and involve uncertainties and matters of significant judgments and therefore cannot be determined with precision. Changes in assumptions could significantly affect these estimates.

 

8. Net Income (Loss) Per Common Share

 

Our consolidated statements of operations present basic and diluted net income (loss) per common share. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted net income (loss) per common share reflects the dilutive effects of RSUs. The treasury stock method was used to determine the dilutive effect of potentially dilutive securities. Due to the net loss for the three months ended September 30, 2012, all 340,000 shares of common stock equivalents were excluded from diluted net income (loss) per common share because they were anti-dilutive. There were no potentially dilutive securities for the three months ended September 30, 2011.

 

9. Accumulated Other Comprehensive Income (Loss)

 

Accumulated other comprehensive income (loss) was as follows:

 

   As of and for the 
   Three Months Ended September 30, 
   2012   2011 
   (In thousands) 
         
Net minimum pension liability, beginning of year  $(1,448)  $(544)
Three months' activity in minimum pension liability, net of tax   -    - 
Net minimum pension liability, September 30   (1,448)   (544)
           
Net cumulative translation adjustment, beginning of year   (38,028)   (31,992)
Three months' activity in cumulative translation adjustment, net of tax   5,477    (7,378)
Net cumulative translation adjustment, September 30   (32,551)   (39,370)
           
Accumulated other comprehensive income (loss)  $(33,999)  $(39,914)

 

10. Income Taxes

 

The income tax benefit was $2.4 million for the three months ended September 30, 2012 on a pre-tax loss of $16.5 million. We recorded an income tax benefit for the three months ended September 30, 2011 of $3.3 million on a pre-tax loss of $8.3 million. The effective income tax rate for both periods differed from the amount computed by applying the U.S. federal income tax rate to income before taxes primarily due to foreign, state and local income taxes, including U.S. income tax on certain foreign net income that we anticipate will be repatriated to the U.S.

 

10
 

 

The income tax benefit for the three months ended September 30, 2012 reflects a discrete benefit of $116,000 relating to a statutory income tax rate reduction in the U.K. and a reduction of a deferred tax liability related to the repatriation of funds from our Chinese subsidiary largely offset by a true-up of a deferred tax item in the U.K. The income tax benefit for the three months ended September 30, 2011 reflects a discrete benefit of $700,000 relating to a reduction in the statutory income tax rate in the U.K.

 

Absent the discrete items, the effective tax rates were 14% and 31% for the three months ended September 30, 2012 and 2011, respectively. The current year’s provision was a combination of projected annual U.S. tax benefit on a domestic book loss and foreign tax expense on foreign earnings. The prior year’s provision was a combination of projected annual U.S. tax expense on domestic earnings and foreign tax expense on foreign earnings. The resulting projected net consolidated income tax rate was applied against year-to-date pre-tax income to arrive at the year-to-date provision before adjustment for discrete items.

 

In the three months ended September 30, 2012 and 2011, we paid income taxes of $1.2 million and $3.5 million and received refunds of $843,000 and $94,000, respectively.

 

11. Legal Matters

 

We have identified instances of noncompliance with the International Traffic in Arms Regulations, or ITAR, in certain of our past business activities as well as in the pre-acquisition business activities of certain acquired companies. These include the inadvertent misclassification and/or export of products without the required license and the disclosure of controlled technology to certain foreign national employees. These matters were formally disclosed to the U.S. Department of State from time to time from fiscal 2007 through fiscal 2012. Matters resolved to date have been without penalty. At this time it is not possible to determine whether any fines or other penalties will be assessed against us or the materiality of the outcome of the remaining ITAR matters.

 

In March 2005, we sold the net assets of our shock and vibration control device manufacturing business, which we refer to as VMC. Under the terms of the sale agreements, we retained certain liabilities relating to adverse environmental conditions that existed at the premises occupied by VMC as of the date of sale. We recorded a liability for the estimated remediation costs related to adverse environmental conditions that existed at the VMC premises when it was sold. The accrued environmental liability at September 30, 2012 was $1.3 million, of which $350,000 is expected to be paid within one year.

 

We are also involved in various other claims and legal actions that arise in the ordinary course of business. We do not believe that the ultimate resolution of any of these actions will have a material adverse effect on our business, results of operations, financial position, liquidity or capital resources.

 

12. Business Segments

 

We are a global provider of radio frequency, or RF, and microwave integrated circuits, components and systems used in the design, development and maintenance of technically demanding, high-performance wireless communication systems. Our solutions include highly specialized microelectronic components and test and measurement equipment used by companies in the space, avionics, defense, commercial wireless communications, medical and other markets. Approximately 32% and 34% of our sales for the three months ended September 30, 2012 and 2011, respectively, were to agencies of the United States government or to prime defense contractors or subcontractors of the United States government. No customer constituted more than 10% of sales during any of the periods presented. Inter-segment sales were not material and have been eliminated from the tables below.

 

11
 

 

The majority of our operations are located in the United States. We also have operations in Europe and Asia, with our most significant non-U.S. operations in the U.K. Net sales from facilities located in the U.K. were $35.3 million and $34.8 million for the three months ended September 30, 2012 and 2011, respectively. Total assets of the U.K. operations were $177.4 million as of September 30, 2012 and $177.9 million as of June 30, 2012.

 

Net sales, based on the customers’ locations, attributed to the United States and other regions were as follows:

 

   Three Months Ended September 30, 
   2012   2011 
   (In thousands) 
         
United States of America  $79,792   $90,186 
Europe and Middle East   35,808    33,304 
Asia and Australia   22,149    26,609 
Other regions   3,404    4,785 
   $141,153   $154,884 

 

We organize our operations into two segments: Aeroflex Microelectronic Solutions, or AMS, and Aeroflex Test Solutions, or ATS. We engineer, manufacture and market a diverse range of products in each of our segments.

 

AMS offers a broad range of microelectronics products and is a leading provider of high-performance, high reliability specialty microelectronics components. Its products include high reliability, or HiRel, microelectronics/semiconductors, RF and microwave components, mixed-signal/digital Application Specific Integrated Circuits (“ASICs”) and motion control products. ATS is a leading provider of a broad line of specialized test and measurement equipment. Its products include wireless test equipment, military radio and private mobile radio test equipment, avionics test equipment, synthetic test equipment and general purpose test equipment.

 

12
 

 

Selected financial data by segment was as follows:

 

   Three Months Ended September 30, 
   2012   2011 
   (In thousands) 
Net sales          
- Microelectronic solutions ("AMS")  $74,450   $81,805 
- Test solutions ("ATS")   66,703    73,079 
Net sales  $141,153   $154,884 
           
Segment adjusted operating income          
- AMS  $15,413   $19,388 
- ATS   2,206    1,829 
- General corporate expense   (4,026)   (3,420)
Adjusted operating income   13,593    17,797 
           
Amortization of acquired intangibles          
- AMS   (8,833)   (9,033)
- ATS   (5,747)   (6,703)
Share-based compensation          
- Corporate   (458)   (600)
- AMS   (109)   - 
- ATS   (69)   - 
Restructuring charges          
- AMS   (204)   (376)
- ATS   (3,063)   (60)
Business acquisition and divestiture related costs - Corporate   (597)   (14)
Increase in fair value of acquisition contingent          
  consideration liability - Corporate   -    (403)
Current period impact of acquisition related adjustments          
- AMS   (9)   (38)
- ATS   22    23 
- Corporate   (55)   (55)
Operating income (loss) (GAAP)   (5,529)   538 
           
Interest expense   (10,078)   (8,574)
Write-off of deferred financing costs   (597)   - 
Other income (expense), net   (289)   (295)
Income (loss) before income taxes  $(16,493)  $(8,331)

 

Management evaluates the operating results of our two segments based upon adjusted operating income, which is pre-tax operating income before costs related to amortization of acquired intangibles, share-based compensation, restructuring charges, business acquisition and divestiture related expenses and the impact of any acquisition related adjustments. We have set out above our adjusted operating income by segment and in the aggregate, and have provided a reconciliation of adjusted operating income to operating income on a GAAP basis and income (loss) before income taxes for the periods presented.

 

13
 

 

 

ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Unless the context requires otherwise, (i) “we”, “our”, “us”, or the “Company” refer to Aeroflex Holding Corp. and subsidiaries, (ii) “Sponsors” refers collectively to affiliates of or funds managed by The Veritas Capital Fund III, L.P., Golden Gate Private Equity, Inc., and GS Direct, L.L.C., which indirectly control the Company, and (iii) “fiscal” refers to the twelve months ended June 30 of the applicable year. For example, “fiscal 2012” refers to the twelve months ended June 30, 2012.

 

Forward-Looking Statements

 

This report contains "forward-looking statements". All statements other than statements of historical fact are "forward-looking" statements for purposes of the U.S. federal and state securities laws. These statements may be identified by the use of forward-looking terminology such as "anticipate", "believe", "continue", "could", "estimate", "expect", "intend", "may", "might", "plan", "potential", "predict", "should" or "will" or the negative thereof or other variations thereon or comparable terminology.

 

We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. These and other important factors may cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. A listing of some of the key factors that could cause actual results to differ from our expectations is included under the caption “Risk Factors” in our fiscal 2012 Form 10-K.

 

Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included in this report are made only as of the date hereof. We undertake no obligation to update or revise any forward-looking statements, either to reflect new developments, or for any other reason, except as required by law.

 

Overview

 

Company Background

 

We are a leading global provider of RF and microwave integrated circuits, components and systems used in the design, development and maintenance of technically demanding, high-performance wireless communication systems. Our solutions include highly specialized microelectronic components and test and measurement equipment used by companies in the (i) space, avionics, defense; (ii) commercial wireless communications; and (iii) medical and other markets. We have targeted customers in these end markets because we believe our solutions address their technically demanding requirements. We were founded in 1937 and have proprietary technology that is based on extensive know-how and a long history of research and development focused on specialized technologies, often in collaboration with our customers.

 

Business Segments

 

Our business segments and major products included in each segment are as follows:

 

Microelectronic Solutions (“AMS”)

 

·HiRel microelectronics/semiconductors
·RF and microwave components
·Mixed-signal/digital ASICs
·Motion control products

 

14
 

 

Test Solutions (“ATS”)

 

·Wireless test equipment
·Military radio and Private Mobile Radio, or PMR, test equipment
·Avionics test equipment
·Synthetic test equipment
·General purpose test equipment

  

Results of Operations

 

The following table sets forth our historical results of operations as a percentage of net sales for the periods indicated below:

 

   Three Months Ended September 30, 
   2012   2011 
Net sales   100.0%   100.0%
Cost of sales   51.2    49.3 
 Gross profit   48.8    50.7 
           
Operating expenses:          
Selling, general and administrative costs   25.3    23.9 
Research and development costs   14.8    15.7 
Amortization of acquired intangibles   10.3    10.2 
Restructuring charges   2.3    0.3 
Change in fair value of acquisition contingent consideration liability   -    0.3 
Total operating expenses   52.7    50.4 
           
Operating income (loss)   (3.9)   0.3 
           
Other income (expense):          
Interest expense   (7.1)   (5.5)
Write-off of deferred financing costs   (0.4)   - 
Other income (expense), net   (0.2)   (0.2)
           
Income (loss) before income taxes   (11.6)   (5.4)
Provision (benefit) for income taxes   (1.7)   (2.1)
           
Net income (loss)   (9.9)%   (3.3)%

 

15
 

 

Three Months Ended September 30, 2012 Compared to Three Months Ended September 30, 2011

 

The end markets that we operate in continue to be challenged by macro-economic factors, including the European financial crisis and uncertainty over U.S. government spending, both of which have caused customers to be more conservative with their buying patterns.

 

Our experienced senior management team constantly reviews the Company’s operations, continually looks for additional efficiencies and is not hesitant to take the actions needed to improve the Company’s profitability based on our current level of business. For instance, during fiscal 2012 we initiated cost saving measures by reducing personnel at various locations worldwide. These activities continued in the first quarter of fiscal 2013, primarily with the reorganization of our European ATS business to make its operations more focused and appropriate for the sales level that we are currently experiencing, as well as positioning us for the opportunity to achieve future growth.

 

Net Sales. Net sales decreased $13.7 million, or 9%, to $141.2 million for the three months ended September 30, 2012 from $154.9 million for the three months ended September 30, 2011.

 

 

Net Sales 
Three Months       % of       % of     
Ended       Consolidated       Consolidated     
September 30,   AMS   Net Sales   ATS   Net Sales   Total 
(In thousands, except percentages)                     
                      
 2012   $74,450    52.7%  $66,703    47.3%  $141,153 
 2011   $81,805    52.8%  $73,079    47.2%  $154,884 

 

 

Net sales in the AMS segment decreased $7.4 million, or 9%, to $74.5 million for the three months ended September 30, 2012 from $81.8 million for the three months ended September 30, 2011. This sales decrease was primarily attributable to volume driven reductions of HiRel microelectronics/semiconductors due to program delays, combined with government budgetary constraints on defense and space programs; mixed-signal/digital Application Specific Integrated Circuits (“ASICs”); and motion control products.

 

Net sales in the ATS segment decreased $6.4 million, or 9%, to $66.7 million for the three months ended September 30, 2012 from $73.1 million for the three months ended September 30, 2011. The decrease was attributable to a large shipment of radio test sets in the first quarter of fiscal 2012, not repeated in fiscal 2013, and a volume driven reduction in sales of avionics test equipment.

 

Gross Profit. Gross profit equals net sales less cost of sales. Cost of sales includes materials, direct labor, amortization of capitalized software development costs and overhead expenses such as engineering labor, fringe benefits, depreciation, allocable occupancy costs and manufacturing supplies.

 

16
 

 

On a consolidated basis, gross profit was $68.9 million, or 48.8% of net sales, for the three months ended September 30, 2012 compared to $78.5 million, or 50.7% of net sales, for the three months ended September 30, 2011.

 

Gross Profit 
                          
Three Months       % of       % of       % of 
Ended       Net       Net       Net 
September 30,   AMS   Sales   ATS   Sales   Total   Sales 
(In thousands, except percentages)                         
                                 
2012   $36,449    49.0%  $32,450    48.6%  $68,899    48.8%
2011   $41,022    50.1%  $37,497    51.3%  $78,519    50.7%

 

Gross margins in the AMS segment were 49.0% for the three months ended September 30, 2012 and 50.1% for the three months ended September 30, 2011. Gross profit decreased $4.6 million for the three months ended September 30, 2012 as compared to the three months ended September 30, 2011 largely due to the reduction in sales. The decrease in gross margin is principally attributable to product mix.

 

Gross margins in the ATS segment were 48.6% for the three months ended September 30, 2012 and 51.3% for the three months ended September 30, 2011. Gross profit decreased $5.0 million for the three months ended September 30, 2012 as compared to the three months ended September 30, 2011 largely due to the reduction in sales. The decrease in gross margin is principally attributable to product mix.

 

Selling, General and Administrative Costs. Selling, general and administrative (“SG&A”) costs include office and management salaries, fringe benefits, commissions, insurance and professional fees.

 

On a consolidated basis, SG&A costs decreased $1.4 million when comparing the three months ended September 30, 2012 to the three months ended September 30, 2011, primarily due to cost reductions in Europe of $1.2 million. The reduction in sales caused SG&A, as a percentage of sales, to increase from 24.0% to 25.3% when comparing the three months ended September 30, 2011 to the three months ended September 30, 2012.

 

 

Selling, General and Administrative Costs 
                              
Three Months       % of       % of           % of 
Ended       Net       Net           Net 
September 30,   AMS   Sales   ATS   Sales   Corporate   Total   Sales 
 (In thousands, except percentages)                                    
                                      
 2012   $12,271    16.5%  $18,296    27.4%  $5,136   $35,703    25.3%
 2011   $13,023    15.9%  $20,019    27.4%  $4,089   $37,131    23.9%

  

Research and Development Costs. Research and development costs include materials, engineering labor and allocated overhead.

 

On a consolidated basis, research and development costs decreased $3.4 million for the three months ended September 30, 2012 from the three months ended September 30, 2011.

 

17
 

 

Research and Development Costs
                         
Three Months      % of       % of       % of 
Ended      Net       Net       Net 
September 30,  AMS   Sales   ATS   Sales   Total   Sales 
(In thousands, except percentages)                        
                               
2012  $8,882    11.9%  $11,996    18.0%  $20,878    14.8%
2011  $8,649    10.6%  $15,626    21.4%  $24,275    15.7%

 

Research and development costs in the ATS segment decreased $3.6 million, primarily due to the reduction of R&D contract engineering headcount by 65 people in conjunction with the completion of wireless related development projects near the end of fiscal 2012.

 

Restructuring Charges. On a consolidated basis, restructuring charges were $3.3 million for the three months ended September 30, 2012 compared to $436,000 for the three months ended September 30, 2011. The restructuring charges wereprimarily related to cost savings initiatives which resulted in reductions in personnel at various locations worldwide.

 

The AMS segment incurred total restructuring costs of $204,000 and $376,000 in the three months ended September 30, 2012 and 2011, respectively.

 

The ATS segment incurred restructuring costs related to the reorganization of our European operations of $3.1 million and $60,000 for the three months ended September 30, 2012 and 2011, respectively.

 

Interest Expense. Interest expense increased by $1.5 million to $10.1 million for the three months ended September 30, 2012 from $8.6 million for the three months ended September 30, 2011. Interest expense increased as a result of the 150 basis point increase in our interest rate on May 24, 2012, partially offset by a lower outstanding principal amount due to voluntary debt payments of $80 million in the latter half of fiscal 2012 and $25 million in the three months ended September 30, 2012.

 

Income Taxes. The income tax benefit was $2.4 million for the three months ended September 30, 2012 on a pre-tax loss of $16.5 million. We recorded an income tax benefit for the three months ended September 30, 2011 of $3.3 million on a pre-tax loss of $8.3 million. The effective income tax rate for both periods differed from the amount computed by applying the U.S. federal income tax rate to income before taxes primarily due to foreign, state and local income taxes, including U.S. income tax on certain foreign net income that we anticipate will be repatriated to the U.S.

 

The income tax benefit for the three months ended September 30, 2012 reflects a discrete benefit of $116,000 relating to a statutory income tax rate reduction in the U.K. and a reduction of a deferred tax liability related to the repatriation of funds from our Chinese subsidiary largely offset by a true-up of a deferred tax item in the U.K. The income tax benefit for the three months ended September 30, 2011 reflects a discrete benefit of $700,000 relating to a reduction in the statutory income tax rate in the U.K.

 

Absent the discrete items, the effective tax rates were 14% and 31% for the three months ended September 30, 2012 and 2011, respectively. The current year’s provision was a combination of projected annual U.S. tax benefit on a domestic book loss and foreign tax expense on foreign earnings. The prior year’s provision was a combination of projected annual U.S. tax expense on domestic earnings and foreign tax expense on foreign earnings. The resulting projected net consolidated income tax rate was applied against year-to-date pre-tax income to arrive at the year-to-date provision before adjustment for discrete items.

 

In the three months ended September 30, 2012 and 2011, we paid income taxes of $1.2 million and $3.5 million, respectively.

 

18
 

 

Net Income (Loss). Net income (loss) was $(14.1) million for the three months ended September 30, 2012 and $(5.0) million for the three months ended September 30, 2011.

 

Liquidity and Capital Resources

 

As of September 30, 2012, we had $45.2 million of cash and cash equivalents, $262.1 million in working capital and our current ratio was 3.55 to 1, versus $41.3 million, $289.2 million and 3.70 to 1, respectively, at June 30, 2012.

 

Our principal liquidity requirements are to service our debt and interest and meet our working capital and capital expenditure needs. As of September 30, 2012, we had $616.4 million of debt outstanding, all of which was long-term, under the senior secured term loan. Additionally, at September 30, 2012, we were able to borrow $75.0 million under the revolving portion of our senior secured credit facility, of which none was outstanding.

 

During the three months ended September 30, 2012, we had accumulated cash in excess of our forecasted operating needs. Consistent with our objective to reduce the outstanding term loan balance and reduce our ongoing interest expense, we voluntarily prepaid a total of $25.0 million of our term loan during the three months ended September 30, 2012.

 

As a result of prepayments made to date, there are no required debt principal payments due until fiscal 2018.

 

As of September 30, 2012, we were in compliance with all of the covenants contained in our debt agreement. Certain loan covenants are based on Adjusted EBITDA. Adjusted EBITDA is defined as EBITDA (net income (loss), before interest expense, income taxes, depreciation and amortization) adjusted to add back or subtract certain non-cash, non-recurring and other items, as permitted by various provisions in our debt agreement. Our use of the term Adjusted EBITDA may vary from others in our industry. EBITDA and Adjusted EBITDA are not measures of operating income (loss), performance or liquidity under U.S. GAAP and are subject to important limitations. A reconciliation of net income (loss), which is a U.S. GAAP measure of our operating results, to Adjusted EBITDA, as defined in our debt agreement, is as follows:

 

19
 

 

   Three Months Ended September 30, 
   2012   2011 
   (In thousands) 
         
Net income (loss)  $(14,139)  $(5,042)
Interest expense   10,078    8,574 
Provision (benefit) for income taxes   (2,354)   (3,289)
Depreciation and amortization   20,123    20,974 
EBITDA   13,708    21,217 
           
Restructuring costs and related pro forma savings(a)   3,702    3,002 
Share-based compensation   636    600 
Change in fair value of acquisition contingent  consideration liability   -    403 
Write-off of deferred financing costs   597    - 
Other defined items(b)   797    489 
Adjusted EBITDA  $19,440   $25,711 
           

 

(a)Primarily reflects costs associated with the reorganization of our European operations and consolidation of certain of our U.S. component facilities. Pro forma savings reflect the costs that we estimate would have been eliminated during the fiscal year in which a restructuring occurred had the restructuring occurred as of the first day of that fiscal year. Pro forma savings were estimated to be $434,000 and $2.6 million for the three months ended September 30, 2012 and 2011, respectively. The pro forma savings of $2.6 million for the three months ended September 30, 2011 were not reflected in our Adjusted EBITDA as reported in our September 30, 2011 report on Form 10-Q as they relate to restructuring activities recorded throughout fiscal 2012.

 

(b)Reflects other adjustments required in calculating our debt covenant compliance. These other defined items include legal fees related to litigation and business acquisition and divestiture related costs.

 

Financial covenants in our senior secured credit facility include a maximum leverage ratio of total debt (less up to $15.0 million of unrestricted cash) to Adjusted EBITDA, as defined in our senior secured credit facility. The maximum leverage ratio permitted for the twelve months ended September 30, 2012 was 5.75, whereas our actual leverage ratio was 4.80. The maximum leverage ratio permitted periodically decreases as follows:

 

20
 

 

Effective as of  Maximum 
the Twelve Months  Permitted 
Ending  Leverage Ratio 
      
March 31, 2013   5.50 
September 30, 2013   5.25 
March 31, 2014   5.00 
June 30, 2014   4.50 
September 30, 2014   4.00 
December 31, 2014   3.75 
March 31, 2015   3.50 

 

We believe that, for the balance of fiscal 2013, we will continue to be in compliance with the leverage ratio.

 

Our senior secured credit facility contains restrictions on our activities, including but not limited to covenants that restrict us and our restricted subsidiaries, as defined in our senior secured credit facility, from:

 

·incurring additional indebtedness and issuing disqualified stock or preferred stock;

 

·making certain investments or other restricted payments;

 

·paying dividends and making other distributions with respect to capital stock, or repurchasing, redeeming or retiring capital stock or subordinated debt;

 

·selling or otherwise disposing of assets;

 

·under certain circumstances, issuing or selling equity interests;

 

·creating liens on our assets;

 

·consolidating or merging with, or acquiring in excess of specified annual limitations, another business, or selling or disposing of all or substantially all of our assets; and

 

·entering into certain transactions with our affiliates.

 

If for any reason we fail to comply with the covenants in the senior secured credit facility, we would be in default under the terms of the agreements governing our outstanding debt. If such a default were to occur, the lenders under the senior secured credit facility could elect to declare all amounts outstanding thereunder immediately due and payable, and the lenders would not be obligated to continue to advance funds to us. If the amounts outstanding under these debt agreements are accelerated, our assets may not be sufficient to repay in full the amounts owed.

 

We expect that cash generated from operating activities and availability under the revolving portion of our new senior secured credit facility will be our principal sources of liquidity. Our ability to make payments on and to refinance our indebtedness and to fund working capital needs and planned capital expenditures will depend on our ability to generate cash in the future. This, to a certain extent, is subject to general economic, financial, competitive and other factors that are beyond our control. In addition, to the extent we have consolidated excess cash flows, as defined in the credit agreement governing the senior secured credit facility, we must use specified portions of the excess cash flows to prepay the senior secured credit facility. Based on our current level of operations, we believe our cash flow from operations and available borrowings under our senior secured credit facility will be adequate to meet our liquidity needs for at least the next twelve months. We cannot assure you, however, that our business will generate sufficient cash flow from operations, or that future borrowings will be available in an amount sufficient to enable us to repay our indebtedness at maturity or to fund other liquidity needs. We may need to refinance all or a portion of our indebtedness on or before the maturity thereof. We cannot assure you that we will be able to refinance any of our indebtedness on commercially reasonable terms or at all.

  

21
 

 

 

Cash Flows

 

For the three months ended September 30, 2012, our cash flow provided by operations was $32.0 million, which included cash generated by reductions in accounts receivable of $33.0 million. Our investing activities used cash of $3.8 million, primarily for capital expenditures of $4.1 million. Our financing activities used cash of $25.0 million, primarily for voluntary debt prepayments.

 

For the three months ended September 30, 2011, our cash flow used by operations was $1.2 million. Our investing activities used cash of $4.7 million, virtually all for capital expenditures. Our financing activities used cash of $1.9 million, primarily for debt repayments.

 

Capital Expenditures

 

Capital expenditures were $4.1 million and $4.7 million for the three months ended September 30, 2012 and 2011, respectively. Our capital expenditures primarily consist of equipment replacements.

 

Contractual Obligations

 

There have been no material changes in our contractual obligations as disclosed in our fiscal 2012 Form 10-K.

 

Off-Balance Sheet Arrangements

 

We do not maintain any off-balance sheet arrangements, transactions, obligations or other relationships with unconsolidated entities that would be expected to have material current or future effect upon our results of operations or financial condition.

 

Critical Accounting Policies and Estimates

 

Information regarding our critical accounting policies and estimates appears within the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our fiscal 2012 Form 10-K. During the three month period ended September 30, 2012, there were no significant changes to any critical accounting policies or to the related estimates and judgments involved in applying those policies.

 

Recent Accounting Pronouncements

 

For information with respect to recent accounting pronouncements and the impact of these pronouncements on our consolidated financial statements, see Note 1 of Notes to Unaudited Condensed Consolidated Financial Statements included elsewhere in this Quarterly Report.

 

22
 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Interest Rate Risk. We are subject to interest rate risk in connection with borrowings under our senior secured credit facility. We currently do not have interest rate swap agreements hedging this debt. As of September 30, 2012, there was $616.4 million outstanding at adjusted LIBOR plus 4.5% under the term-loan portion of the senior secured credit facility, all of which is subject to variable interest rates. The adjusted LIBOR, as defined in the senior secured credit facility, has a floor of 1.25% on the term loan. Based on LIBOR at September 30, 2012, an increase of 1% in interest rates would result in a 0.11% increase, due to the 1.25% floor, or a $687,000 increase in our annual interest expense. Any 1% increase in interest rates above the 1.25% floor would result in a $6.2 million increase in our annual interest expense. A 1% change in interest rates would result in a $760,000 change in our annual interest expense on the revolving loan borrowings, assuming the entire $75.0 million was outstanding. Any debt we incur in the future may also bear interest at floating rates.

 

Foreign Currency Risk. Foreign currency contracts are used to protect us from exchange rate fluctuation from the time customers are invoiced in local currency until such currency is exchanged for U.S. dollars. We periodically enter into foreign currency contracts, which are not designated as hedges, and the change in the fair value is included in income currently within other income (expense). As of September 30, 2012, we had $31.4 million of notional value foreign currency forward contracts maturing through October 31, 2012. Notional amounts do not quantify risk or represent assets or liabilities, but are used in the calculation of cash settlements under the contracts. The fair value of these contracts at September 30, 2012 was a liability of $2,000. If foreign currency exchange rates (primarily the British pound and the Euro) change by 10% from the levels at September 30, 2012, the effect on our comprehensive income would be approximately $15.9 million.

 

Inflation Risk. Inflation has not had a material impact on our results of operations or financial condition during the preceding three years.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Our disclosure controls and procedures under the Securities Exchange Act of 1934, as amended, are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the Securities and Exchange Commission. Our disclosure controls and procedures are also designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. Our Principal Executive Officer and our Principal Financial Officer, with the assistance from other members of management, have reviewed the effectiveness of our disclosure controls and procedures as of September 30, 2012 and, based on their evaluation, have concluded that the disclosure controls and procedures were effective as of such date.

 

There have been no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2012 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

23
 

 

PART II – OTHER INFORMATION

 

 

Item 1. Legal Proceedings

 

There have been no material changes in our legal proceedings disclosed in our fiscal 2012 Form 10-K.

 

Item 1A. Risk Factors

 

There have been no material changes in our risk factors disclosed in our fiscal 2012 Form 10-K.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None

 

Item 3. Defaults upon Senior Securities

 

None

 

Item 4. Mine Safety Disclosures

 

Not applicable

 

Item 5. Other Information

 

None

  

24
 

Item 6. Exhibits

 

 

Exhibit No.   Exhibit Description
     
10.1   Executive Employment Agreement, entered into as of September 28, 2012, by and between Aeroflex Incorporated and Andrew F. Kaminsky (incorporated by reference to Registrant’s Current Report on Form 8-K filed October 3, 2012).
10.2  

Amendment No. 6 to Employment Agreement, dated as of September 28, 2012, by and between Aeroflex Incorporated and John Adamovich, Jr. (incorporated by reference to Registrant’s Current Report on Form 8-K filed October 3, 2012).

 

10.3  

Amendment No. 1 to Employment Agreement, dated as of September 28, 2012, by and between Aeroflex Incorporated and Edward S. Wactlar (incorporated by reference to Registrant’s Current Report on Form 8-K filed October 3, 2012).

 

31.1  

Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Chief Executive Officer)

 

31.2  

Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Chief Financial Officer)

 

31.3  

Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Principal Accounting Officer)

 

32.1  

Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Chief Executive Officer)

 

32.2  

Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Chief Financial Officer)

 

101.INS  

XBRL Instance Document

 

101.SCH  

XBRL Taxonomy Extension Schema Document

 

101.CAL  

XBRL Taxonomy Extension Calculation Linkbase Document

 

101.LAB  

XBRL Taxonomy Extension Label Linkbase Document

 

101.PRE  

XBRL Taxonomy Extension Presentation Linkbase Document

 

101.DEF  

XBRL Taxonomy Extension Definition Linkbase Document

 

 

25
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 AEROFLEX HOLDING CORP.
   
  /s/ John Adamovich, Jr.
John Adamovich, Jr.
   Senior Vice President and
  Chief Financial Officer
   (Principal Financial Officer)

 

November 8, 2012

 

26
 

 

EXHIBIT INDEX

 

Exhibit No.  

Exhibit Description

     
10.1   Executive Employment Agreement, entered into as of September 28, 2012, by and between Aeroflex Incorporated and Andrew F. Kaminsky (incorporated by reference to Registrant’s Current Report on Form 8-K filed October 3, 2012).
     
10.2  

Amendment No. 6 to Employment Agreement, dated as of September 28, 2012, by and between Aeroflex Incorporated and John Adamovich, Jr. (incorporated by reference to Registrant’s Current Report on Form 8-K filed October 3, 2012).

 

10.3  

Amendment No. 1 to Employment Agreement, dated as of September 28, 2012, by and between Aeroflex Incorporated and Edward S. Wactlar (incorporated by reference to Registrant’s Current Report on Form 8-K filed October 3, 2012).

 

31.1  

Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Chief Executive Officer)

 

31.2  

Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Chief Financial Officer)

 

31.3  

Certification pursuant to Rules 13a-14(a)/15d-14a as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Principal Accounting Officer)

 

32.1  

Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Chief Executive Officer)

 

32.2  

Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Chief Financial Officer)

 

101.INS   XBRL Instance Document
     
101.SCH   XBRL Taxonomy Extension Schema Document
     
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document
     
101.LAB   XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document
     
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document

 

 

27